Cargando…
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
BACKGROUND: Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by the development of benign nerve-sheath tumors, which transform to malignant peripheral nerve-sheath tumors (MPNST) in about 8 to 13% of patients with NF1. MPNST are invasive sarcomas with extremely poor progno...
Autores principales: | Park, Su-Jin, Sawitzki, Birgit, Kluwe, Lan, Mautner, Victor F, Holtkamp, Nikola, Kurtz, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648455/ https://www.ncbi.nlm.nih.gov/pubmed/23618374 http://dx.doi.org/10.1186/1741-7015-11-109 |
Ejemplares similares
-
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
por: Farschtschi, Said, et al.
Publicado: (2020) -
Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
por: Farschtschi, Said, et al.
Publicado: (2016) -
Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours
por: Bradtmöller, Maren, et al.
Publicado: (2012) -
Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
por: Spyra, Melanie, et al.
Publicado: (2011) -
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients
por: Frahm, Silke, et al.
Publicado: (2004)